Global Information would like to present a market research report, "The US Pharmaceutical Market 2009-2024" by Visiongain.
The US markets vast economy, high standard of living, minimal pricing controls and strong intellectual property rights help make it the world s most dominant pharma market. The US also has one of the most stringent regulatory environments in the world. The US is on the verge of reforming its healthcare system. Under most schemes, the reforms will not take full effect until 2013. However, the prospect of reform could have a psychological impact even before then. This market study discusses important US healthcare issues, and takes potential reforms into account in its forecasts. How would wider insurance coverage affect prescription drug sales? Will governmental price negotiations be approved? If governmental negotiation is approved, how would that affect sales revenues?